Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Imfinzi plus tremelimumab demonstrated promising clinical activity and tolerability in patients with advanced liver cancer
-
Tagrisso demonstrated unprecedented disease-free survival in the adjuvant treatment of Stage IB-IIIA patients with EGFR-mutated lung cancer
-
AstraZeneca collaborates with ArcherDX to use personalised cancer assays to detect minimal residual disease in lung cancer trials
-
Enhertu granted Orphan Drug Designation in the US for gastric cancer
-
AstraZeneca advances response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine
-
Lynparza approved in the US for HRR gene-mutated metastatic castration-resistant prostate cancer
-
Enhertu granted Breakthrough Therapy Designation in the US for HER2-mutant metastatic non-small cell lung cancer
-
Bevespi Aerosphere approved in China for patients with COPD
-
AstraZeneca advances the science of cancer medicine with practice-changing data at the ASCO20 Virtual Scientific Program
-
Enhertu granted Breakthrough Therapy Designation in the US for HER2-positive metastatic gastric cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
